• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者的尿排泄物质:存在尿路结石风险?

Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?

作者信息

Hoppe B, Hesse A, Brömme S, Rietschel E, Michalk D

机构信息

University Children's Hospital Cologne, Germany.

出版信息

Pediatr Nephrol. 1998 May;12(4):275-9. doi: 10.1007/s004670050452.

DOI:10.1007/s004670050452
PMID:9655356
Abstract

Patients with cystic fibrosis (CF) have an increased risk of urolithiasis/nephrocalcinosis. To determine potential mechanisms responsible, we studied the urinary excretion of lithogenic and stone-inhibitory substances and calculated the urinary saturation for calcium-oxalate (CaOx), brushite (CaHPO4), and uric acid (UA). We examined 24-h urines in 63 patients with CF (34 female, 29 male) aged 5 months to 36 years. Renal ultrasonography was performed at the time of urine collection. Hyperoxaluria was found in 25 patients (range 0.51-1.71 mmol/1.73 m2 per 24 h). Urinary Ca was increased in 13 patients (4.1-8.22 mg/kg per 24 h). Hyperuricosuria was found in 16 patients (5.2-18.0 mmol/1.73 m2 per 24 h) and hypocitraturia in 14 patients (0.07-1.14 mmol/1.73 m2 per 24 h). CaOx saturation was elevated in 26 patients, related to hyperoxaluria in 19 patients. CaHPO4 saturation was increased in 19 patients and UA saturation in 11 patients. Urolithiasis in situ was diagnosed in 1 patient; 3 patients previously had renal stones; 4 patients had present nephrocalcinosis. Elevated excretion of lithogenic substances and urinary supersaturation might lead to the higher risk of urolithiasis/nephrocalcinosis in patients with CF.

摘要

囊性纤维化(CF)患者发生尿石症/肾钙质沉着症的风险增加。为确定其潜在机制,我们研究了致石和抑石物质的尿排泄情况,并计算了草酸钙(CaOx)、磷酸氢钙(CaHPO4)和尿酸(UA)的尿饱和度。我们检测了63例年龄在5个月至36岁之间的CF患者(34例女性,29例男性)的24小时尿液。在收集尿液时进行了肾脏超声检查。发现25例患者存在高草酸尿症(范围为每24小时0.51 - 1.71 mmol/1.73 m2)。13例患者尿钙升高(每24小时4.1 - 8.22 mg/kg)。16例患者存在高尿酸尿症(每24小时5.2 - 18.0 mmol/1.73 m2),14例患者存在低枸橼酸尿症(每24小时0.07 - 1.14 mmol/1.73 m2)。26例患者的CaOx饱和度升高,其中19例与高草酸尿症有关。19例患者的CaHPO4饱和度增加,11例患者的UA饱和度增加。1例患者诊断为原位尿石症;3例患者既往有肾结石;4例患者存在肾钙质沉着症。致石物质排泄增加和尿过饱和可能导致CF患者发生尿石症/肾钙质沉着症的风险更高。

相似文献

1
Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?囊性纤维化患者的尿排泄物质:存在尿路结石风险?
Pediatr Nephrol. 1998 May;12(4):275-9. doi: 10.1007/s004670050452.
2
Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.吸收性高草酸尿症会增加囊性纤维化患者患尿路结石或肾钙质沉着症的风险。
Am J Kidney Dis. 2005 Sep;46(3):440-5. doi: 10.1053/j.ajkd.2005.06.003.
3
Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.饮食中草酸盐增加并不会提高高钙尿症大鼠尿草酸钙饱和度。
Kidney Int. 1999 Feb;55(2):602-12. doi: 10.1046/j.1523-1755.1999.00281.x.
4
Oxalate and calcium excretion in cystic fibrosis.囊性纤维化患者的草酸盐和钙排泄情况
Arch Dis Child. 2000 Sep;83(3):244-7. doi: 10.1136/adc.83.3.244.
5
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.一种基于波恩风险指数的儿童尿路结石诊断新方法。
Pediatr Nephrol. 2008 Jul;23(7):1123-8. doi: 10.1007/s00467-008-0786-1. Epub 2008 Mar 12.
6
Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.含碳酸氢盐矿泉水对草酸钙尿路结石多次发作患者尿路结石形成风险影响的临床研究
World J Urol. 2007 Jun;25(3):315-23. doi: 10.1007/s00345-007-0144-0. Epub 2007 Feb 28.
7
Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.尿pH值和尿钙的昼夜变化在尿路结石形成中的作用:一项门诊患者研究
Int J Urol. 2001 Oct;8(10):525-31; discussion 532.
8
Factors increasing the risk for stone formation in adult patients with cystic fibrosis.成年囊性纤维化患者结石形成风险增加的因素。
Nephrol Dial Transplant. 2006 Jul;21(7):1870-5. doi: 10.1093/ndt/gfl067. Epub 2006 Apr 4.
9
Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect.
J Pediatr. 1990 Apr;116(4):556-60. doi: 10.1016/s0022-3476(05)81602-6.
10
Role of the urinary calcium in the growth of calcium stone.尿钙在钙结石形成中的作用。
Hinyokika Kiyo. 2004 Jul;50(7):451-5.

引用本文的文献

1
Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis.三联CFTR调节剂疗法对囊性纤维化患者肾脏的影响。
Clin Kidney J. 2024 Aug 27;17(10):sfae256. doi: 10.1093/ckj/sfae256. eCollection 2024 Oct.
2
Lumasiran treatment in pediatric patients with PH1: real-world data within a compassionate use program in Italy.鲁马西拉治疗1型原发性高草酸尿症儿科患者:意大利同情用药项目中的真实世界数据
Clin Kidney J. 2024 Mar 28;17(5):sfae090. doi: 10.1093/ckj/sfae090. eCollection 2024 May.
3
Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1.
病例报告:鲁马西拉治疗对产前诊断为1型原发性高草酸尿症的晚期早产儿的疗效
Front Pediatr. 2024 Jan 16;11:1338909. doi: 10.3389/fped.2023.1338909. eCollection 2023.
4
Hydration and Nephrolithiasis in Pediatric Populations: Specificities and Current Recommendations.小儿人群的水合作用与肾结石病:特点和当前建议。
Nutrients. 2023 Feb 1;15(3):728. doi: 10.3390/nu15030728.
5
Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management.了解囊性纤维化合并症及其对营养管理的影响。
Nutrients. 2022 Feb 28;14(5):1028. doi: 10.3390/nu14051028.
6
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.药物相关性肾结石和结晶性肾病:病理生理学、预防和治疗。
Drugs. 2018 Feb;78(2):163-201. doi: 10.1007/s40265-017-0853-7.
7
Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?草酸降解微生物或草酸降解酶:哪一种是复发性结石病中草酸钙尿石酶促溶解的未来治疗方法?
Urolithiasis. 2016 Feb;44(1):45-50. doi: 10.1007/s00240-015-0845-6. Epub 2015 Dec 8.
8
Primary and secondary hyperoxaluria: Understanding the enigma.原发性和继发性高草酸尿症:解读谜团。
World J Nephrol. 2015 May 6;4(2):235-44. doi: 10.5527/wjn.v4.i2.235.
9
Renal diseases in adults with cystic fibrosis: a 40 year single centre experience.成人囊性纤维化患者的肾脏疾病:40年单中心经验
J Nephrol. 2015 Oct;28(5):585-91. doi: 10.1007/s40620-015-0179-z. Epub 2015 Feb 25.
10
Predisposing factors for nephrolithiasis and nephrocalcinosis in cystic fibrosis.囊性纤维化中肾结石和肾钙沉着症的易感因素。
Iran J Pediatr. 2011 Mar;21(1):65-71.